225 related articles for article (PubMed ID: 19801645)
21. 14-3-3zeta contributes to tyrosine hydroxylase activity in MN9D cells: localization of dopamine regulatory proteins to mitochondria.
Wang J; Lou H; Pedersen CJ; Smith AD; Perez RG
J Biol Chem; 2009 May; 284(21):14011-9. PubMed ID: 19289463
[TBL] [Abstract][Full Text] [Related]
22. Identification of a 14-3-3 binding sequence in the common beta chain of the granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3), and IL-5 receptors that is serine-phosphorylated by GM-CSF.
Stomski FC; Dottore M; Winnall W; Guthridge MA; Woodcock J; Bagley CJ; Thomas DT; Andrews RK; Berndt MC; Lopez AF
Blood; 1999 Sep; 94(6):1933-42. PubMed ID: 10477722
[TBL] [Abstract][Full Text] [Related]
23. The 14-3-3 protein affects the conformation of the regulatory domain of human tyrosine hydroxylase.
Obsilova V; Nedbalkova E; Silhan J; Boura E; Herman P; Vecer J; Sulc M; Teisinger J; Dyda F; Obsil T
Biochemistry; 2008 Feb; 47(6):1768-77. PubMed ID: 18181650
[TBL] [Abstract][Full Text] [Related]
24. Catalytic domain surface residues mediating catecholamine inhibition in tyrosine hydroxylase.
Briggs GD; Bulley J; Dickson PW
J Biochem; 2014 Mar; 155(3):183-93. PubMed ID: 24334288
[TBL] [Abstract][Full Text] [Related]
25. Reversible membrane interaction of BAD requires two C-terminal lipid binding domains in conjunction with 14-3-3 protein binding.
Hekman M; Albert S; Galmiche A; Rennefahrt UEE; Fueller J; Fischer A; Puehringer D; Wiese S; Rapp UR
J Biol Chem; 2006 Jun; 281(25):17321-17336. PubMed ID: 16603546
[TBL] [Abstract][Full Text] [Related]
26. Effects of phosphorylation on binding of catecholamines to tyrosine hydroxylase: specificity and thermodynamics.
Ramsey AJ; Fitzpatrick PF
Biochemistry; 2000 Feb; 39(4):773-8. PubMed ID: 10651643
[TBL] [Abstract][Full Text] [Related]
27. Phosphorylation at serine 31 targets tyrosine hydroxylase to vesicles for transport along microtubules.
Jorge-Finnigan A; Kleppe R; Jung-Kc K; Ying M; Marie M; Rios-Mondragon I; Salvatore MF; Saraste J; Martinez A
J Biol Chem; 2017 Aug; 292(34):14092-14107. PubMed ID: 28637871
[TBL] [Abstract][Full Text] [Related]
28. The binding of 14-3-3γ to membranes studied by intrinsic fluorescence spectroscopy.
Bustad HJ; Underhaug J; Halskau O; Martinez A
FEBS Lett; 2011 Apr; 585(8):1163-8. PubMed ID: 21420405
[TBL] [Abstract][Full Text] [Related]
29. Tyrosine hydroxylase binds tetrahydrobiopterin cofactor with negative cooperativity, as shown by kinetic analyses and surface plasmon resonance detection.
Flatmark T; Almås B; Knappskog PM; Berge SV; Svebak RM; Chehin R; Muga A; Martínez A
Eur J Biochem; 1999 Jun; 262(3):840-9. PubMed ID: 10411647
[TBL] [Abstract][Full Text] [Related]
30. Catalytic core of rat tyrosine hydroxylase: terminal deletion analysis of bacterially expressed enzyme.
Walker SJ; Liu X; Roskoski R; Vrana KE
Biochim Biophys Acta; 1994 May; 1206(1):113-9. PubMed ID: 7910484
[TBL] [Abstract][Full Text] [Related]
31. Cyclin-dependent kinase 5 phosphorylates serine 31 of tyrosine hydroxylase and regulates its stability.
Moy LY; Tsai LH
J Biol Chem; 2004 Dec; 279(52):54487-93. PubMed ID: 15471880
[TBL] [Abstract][Full Text] [Related]
32. The N-terminal SH2 domains of Syk and ZAP-70 mediate phosphotyrosine-independent binding to integrin beta cytoplasmic domains.
Woodside DG; Obergfell A; Talapatra A; Calderwood DA; Shattil SJ; Ginsberg MH
J Biol Chem; 2002 Oct; 277(42):39401-8. PubMed ID: 12171941
[TBL] [Abstract][Full Text] [Related]
33. Regulation of tyrosine hydroxylase by stress-activated protein kinases.
Toska K; Kleppe R; Armstrong CG; Morrice NA; Cohen P; Haavik J
J Neurochem; 2002 Nov; 83(4):775-83. PubMed ID: 12421349
[TBL] [Abstract][Full Text] [Related]
34. Kinetics characterization of c-Src binding to lipid membranes: Switching from labile to persistent binding.
Le Roux AL; Busquets MA; Sagués F; Pons M
Colloids Surf B Biointerfaces; 2016 Feb; 138():17-25. PubMed ID: 26638178
[TBL] [Abstract][Full Text] [Related]
35. Simultaneous measurement of tyrosine hydroxylase activity and phosphorylation in bovine adrenal chromaffin cells.
Cheah TB; Bobrovskaya L; Gonçalves CA; Hall A; Elliot R; Lengyel I; Bunn SJ; Marley PD; Dunkley PR
J Neurosci Methods; 1999 Mar; 87(2):167-74. PubMed ID: 11230813
[TBL] [Abstract][Full Text] [Related]
36. NT5DC2 affects the phosphorylation of tyrosine hydroxylase regulating its catalytic activity.
Nakashima A; Yamaguchi H; Kondo M; Furumura T; Kodani Y; Kaneko YS; Kawata M; Nagasaki H; Nagatsu T; Ota A
J Neural Transm (Vienna); 2020 Dec; 127(12):1631-1640. PubMed ID: 32778969
[TBL] [Abstract][Full Text] [Related]
37. Differential expression of the B'beta regulatory subunit of protein phosphatase 2A modulates tyrosine hydroxylase phosphorylation and catecholamine synthesis.
Saraf A; Virshup DM; Strack S
J Biol Chem; 2007 Jan; 282(1):573-80. PubMed ID: 17085438
[TBL] [Abstract][Full Text] [Related]
38. Phosphorylation of Ser(19) alters the conformation of tyrosine hydroxylase to increase the rate of phosphorylation of Ser(40).
Bevilaqua LR; Graham ME; Dunkley PR; von Nagy-Felsobuki EI; Dickson PW
J Biol Chem; 2001 Nov; 276(44):40411-6. PubMed ID: 11502746
[TBL] [Abstract][Full Text] [Related]
39. Modeled ligand-protein complexes elucidate the origin of substrate specificity and provide insight into catalytic mechanisms of phenylalanine hydroxylase and tyrosine hydroxylase.
Maass A; Scholz J; Moser A
Eur J Biochem; 2003 Mar; 270(6):1065-75. PubMed ID: 12631267
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of dopamine biosynthesis by tetrahydropapaveroline.
Kim YM; Kim MN; Lee JJ; Lee MK
Neurosci Lett; 2005 Sep; 386(1):1-4. PubMed ID: 16026929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
